Omics is Just a Startup

When I was listening the report titled Using Genomics to Explore the Microbial World by Prof. James Tiedje this afternoon, an idea had been daunting in my mind all the time. "Omics is dead" -I forgot where I read this remarks, but it stroke me then and now. Omics is like listing all the components of a computer. However, due to technique limitations and time constraints, we will never be able to get a full list of genes and proteins, though genomics and proteomics optimisticly promised. Even if we could get the full catalogue of human machine, we still can not understand how human body functions and malfunctions, as knowing all the components of a computer does not necessarily imply understanding its working.

Now besides proteomics and genomics, here comes the metabolomics, with similar promising declarations. As the lates Nature essay (Meet the human metabolome)states,

Metabolomics is the study of the raw materials and products of the body's biochemical reactions, molecules that are smaller than most proteins, DNA and other macromolecules. The aim is to be able to take urine, blood or some other body fluid, scan it in a machine and find a profile of tens or hundreds of chemicals that can predict whether an individual is on the road to a disease, say, or likely to experience side-effects from a particular drug.

In fact, researchers in metabolomics are even more optimistic, declaring that

Small changes in the activity of a gene or protein (which may have an unknown impact on the workings of a cell) often create a much larger change in metabolite levels particular concentrations and combinations can reveal something about drugs or disease

However, I am suspecious about their promise. First, considering the great diversity of metabolites in human fluids, we still have not a powerful enough assay to identify the all metabolite in a high-throughout manner and measure their concentrations. Second, the changes in the metabolome is more susceptible to enviromental factors, thus it will be difficult to tell significant changes related to human diseases from temporal fluctuations.

Anyway, let be a little optimistic, omics is just a startup!